Canagliflozin and Brusatol Synergize against LKB1-KEAP1 Co-Mutant NSCLC through AKT Suppression
International Journal of Biological Sciences · 23.04.2026 · 22 (9) · 4618-4632
DOI: 10.7150/ijbs.124757 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Biological Sciences, erschienen am 23.04.2026. Verfasst von Yiguan Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health Sciences, Ministry of Education Frontier Science Centre for Precision Oncology, University of Macau, Macau SAR, China. Hauptthemen laut MEDLINE: Kelch-Like ECH-Associated Protein 1, Quassins, Carcinoma, Non-Small-Cell Lung, Protein Serine-Threonine Kinases. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Health Sciences, Ministry of Education Frontier Science Centre for Precision Oncology, University of Macau, Macau SAR, China.
- Department of Physiological Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, China.
- Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, China; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
Zitieren
APA
Chen, Y., Gao, X. Z., Rong, D., Gao, L., Tang, M., Lu, G., Ling, Z. Q., & Shen, H. M. (2026). Canagliflozin and Brusatol Synergize against LKB1-KEAP1 Co-Mutant NSCLC through AKT Suppression. International Journal of Biological Sciences, 22(9), 4618-4632. https://doi.org/10.7150/ijbs.124757
Vancouver
Chen Y, Gao XZ, Rong D, Gao L, Tang M, Lu G, et al. Canagliflozin and Brusatol Synergize against LKB1-KEAP1 Co-Mutant NSCLC through AKT Suppression. International Journal of Biological Sciences. 2026;22(9):4618-4632. doi:10.7150/ijbs.124757
BibTeX
@article{Chen2026,
author = {Chen, Yiguan and Gao, Xiang-Zheng and Rong, Dade and Gao, Liangliang and Tang, Mingzhu and Lu, Guang and Ling, Zhi-Qiang and Shen, Han-Ming},
title = {Canagliflozin and Brusatol Synergize against LKB1-KEAP1 Co-Mutant NSCLC through AKT Suppression},
journal = {International Journal of Biological Sciences},
year = {2026},
volume = {22},
number = {9},
pages = {4618--4632},
doi = {10.7150/ijbs.124757}
}
EUVIMED